about
Effects of high-dose atorvastatin pretreatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a cardiac magnetic resonance study.Uric Acid Level Has a U-shaped Association with Clinical Outcomes in Patients with Vasospastic Angina.Long-term Survival Benefit of Statin in Patients with Coronary Chronic Total Occlusion without Revascularization.Risk Scoring System to Assess Outcomes in Patients Treated with Contemporary Guideline-Adherent Optimal Therapies after Acute Myocardial Infarction.Understanding the Coronary Bifurcation Stenting.Impact of Natural Mild Hypothermia in the Early Phase of ST-Elevation Myocardial Infarction: Cardiac Magnetic Resonance Imaging StudyPrognostic Value of Admission Blood Glucose Level in Critically Ill Patients Admitted to Cardiac Intensive Care Unit according to the Presence or Absence of Diabetes MellitusSafety and Efficacy of Biodegradable Polymer-biolimus-eluting Stents (BP-BES) Compared with Durable Polymer-everolimus-eluting Stents (DP-EES) in Patients Undergoing Complex Percutaneous Coronary Intervention.The Proximal Optimization Technique Improves Clinical Outcomes When Treated without Kissing Ballooning in Patients with a Bifurcation Lesion.Comparison of Exercise Performance and Clinical Outcome Between Functional Complete and Incomplete RevascularizationOne-Year Clinical Outcomes between Single- versus Multi-Staged PCI for ST Elevation Myocardial Infarction with Multi-Vessel Coronary Artery Disease: from Korea Acute Myocardial Infarction Registry-National Institute of Health (KAMIR-NIH)Clopidogrel versus Aspirin after Dual Antiplatelet Therapy in Acute Myocardial Infarction Patients Undergoing Drug-Eluting StentingLong-Term Outcomes in Patients Undergoing Percutaneous Coronary Intervention with or without Preprocedural Exercise Stress Test
P50
Q35198568-CC5D6301-E530-4B84-B1F3-931F7FBCEBEBQ38700555-564F4205-61BB-4713-9517-9EB21E1E79ECQ55113414-1ACE0F8D-5A44-4260-B736-3B3F452192A4Q55423937-D1BC522F-DD84-4F9E-9F9E-80110AFC9FF5Q55492711-F898570A-1D3B-4134-8F12-318C35FF2FC5Q57494586-0BAD79A6-D549-48D7-B9AC-751A2FC1F605Q64096002-544DD72C-FF43-4260-885F-6C40B0672CB3Q64923340-4F866346-BBD5-40A1-B74E-CA3A46251156Q64949397-54A6F79D-9140-4D0C-AF58-D46D8DFE7614Q89872718-DA298B87-DF37-428D-AD59-19C248234A8DQ89888702-63B083B4-AF35-49CB-826F-7DD0E1FFF740Q92036739-F6927CF9-1369-4BEF-8014-D09D789D84BAQ92391901-F173588C-45EA-40CB-8FF8-78668506AC7B
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Hyeon-Cheol Gwon
@en
Hyeon-Cheol Gwon
@nl
type
label
Hyeon-Cheol Gwon
@en
Hyeon-Cheol Gwon
@nl
prefLabel
Hyeon-Cheol Gwon
@en
Hyeon-Cheol Gwon
@nl
P31
P496
0000-0002-8967-4305